Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
Clinical trial NCT04485156 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04485156
- Sponsor
- Seoul National University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2025-08-01
- Enrollment
- 926
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.